Location: Sheraton Towers Singapore Hotel, Singapore
Do you believe the future of Cell Therapy is Allogeneic?
Cellistic will attend Cell & Gene Therapy World Asia 2025 in Singapore, September 10–11.
As a global CDMO dedicated to allogeneic iPSC-based therapies, Cellistic partners with developers to advance cell therapies from concept to clinic. We combine proven technologies with reliable manufacturing expertise to ensure reproducibility and scalability:
-
STAR-CRISPR™ gene editing and Allo Chassis™ immune-cloaked iPSC lines to enable allogeneic programs
-
Pulse™ for cell line development and Echo™ for differentiation and large-scale manufacturing
-
Comprehensive CDMO services, including analytical testing, process development, QC/QA, and manufacturing in our EMA-certified, FDA compliant manufacturing facility located in Belgium, Europe.
Meet Peter Jaehn, VP Business Development Asia & Europe, who will represent Cellistic at the event.
We look forward to connecting in Singapore and exploring how Cellistic can support your programs with trusted technologies and end-to-end manufacturing solutions.